The age recommended by the Korea Disease Control and Prevention Agency and pharmaceutical companies is 50, and only those who have no history of shingles within the last 6 months can be vaccinated.

Since the rubella antigen causes vertical transmission to the fetus in early pregnancy, it is recommended to avoid pregnancy for 2-3 months after vaccination.

The pneumonia vaccination is available only at medical institutions registered with the Korea Disease Control and Prevention Agency and not at clinics. Therefore, please inquire at a nearby medical institution where you can be vaccinated and visit there. (https://nip.kdca.go.kr)

It depends on the extent of the wound after treatment, and you will not be additionally vaccinated against tetanus if you have been vaccinated within the last 10 years. However, if the wound is wide and 5 years or more have passed since your last vaccination, you may be additionally vaccinated after consulting a doctor for treatment purposes.

There is no single vaccine against pertussis yet, and only combined vaccines mixed with tetanus and diphtheria can be administered. If you have been vaccinated against Tdap within the last 10 years, you do not need to be vaccinated. Pregnant women can be vaccinated from 27 to 36 weeks of pregnancy, and are recommended to be vaccinated every pregnancy to give the formed antibody to the fetus.

You will not be re-vaccinated from the beginning, but will be vaccinated from the delayed turn of vaccination as soon as possible.

It is possible because there will be no difference in antibody formation through immune response even when a person has been cross-inoculated with different hepatitis B vaccines from different manufacturers.

If you did not develop antibodies even after three vaccinations against hepatitis B as an adult, you may be vaccinated three times again and an antibody blood test will be conducted afterward. If the result is still negative, you will be considered a non-responder to the Hepatitis B vaccine and you will not be vaccinated any further.

The current HPV vaccination ages are 9 to 26 years for both men and women. Efficacy has not been proven in men and women after the age of 26, but if the chance of exposure to HPV is small, it can theoretically be expected to prevent cancer.